Complement receptor 3-mediated neurotoxic glial activation contributes to rotenone-induced cognitive decline in mice

Microglia-mediated chronic neuroinflammation has been associated with cognitive decline induced by rotenone, a well-known neurotoxic pesticide used in agriculture. However, the mechanisms remain unclear. This work aimed to elucidate the role of complement receptor 3 (CR3), a highly expressed recepto...

Full description

Bibliographic Details
Published in:	Ecotoxicology and Environmental Safety
Main Authors:	Qinghui Wang, Zhengzheng Ruan, Lu Jing, Ziyang Guo, Xiaomeng Zhang, Jianing Liu, Lu Tian, Wei Sun, Sheng Song, Jau-Shyong Hong, Yen-Yu Ian Shih, Liyan Hou, Qingshan Wang
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Subjects:	Microglia Neuroinflammation Complement receptor 3 Cognitive deficit Parkinson’s disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0147651323010540

Similar Items

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
by: Dongdong Zhang, et al.
Published: (2021-01-01)

Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes
by: Amer Toutonji, et al.
Published: (2023-06-01)

A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage
by: Devin Hatchell, et al.
Published: (2023-06-01)

Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
by: Shan Liu, et al.
Published: (2019-12-01)

Retinal Injury Activates Complement Expression in Müller Cells Leading to Neuroinflammation and Photoreceptor Cell Death
by: Steven J. Tabor, et al.
Published: (2023-06-01)

Complement Receptor 3 Regulates Microglial Exosome Release and Related Neurotoxicity via NADPH Oxidase in Neuroinflammation Associated with Parkinson’s Disease
by: Yu Ma, et al.
Published: (2025-08-01)

Chemokine–complement cascade in glial–vascular units protects neurons from non-biogenic nanoparticles
by: Ari Ogaki, et al.
Published: (2025-07-01)

Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91<sup><it>phox </it></sup>subunit of NADPH oxidase
by: Wang Qingshan, et al.
Published: (2012-02-01)

Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors
by: Feng Xu, et al.
Published: (2023-01-01)

Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy
by: Qi Zhang, et al.
Published: (2020-09-01)

Editorial: Complement in nervous system disease
by: Iliana Michailidou, et al.
Published: (2023-08-01)

Complement C1q-mediated microglial synaptic elimination by enhancing desialylation underlies sevoflurane-induced developmental neurotoxicity
by: Gang Wang, et al.
Published: (2024-04-01)

Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review
by: Deepraj Paul, et al.
Published: (2022-12-01)

Human Microglia Synthesize Neurosteroids to Cope with Rotenone-Induced Oxidative Stress
by: Chiara Lucchi, et al.
Published: (2023-04-01)

Editorial: Expert opinions and perspectives in complement: 2022
by: Marcin Okrój, et al.
Published: (2023-07-01)

Correction: Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
by: Dongdong Zhang, et al.
Published: (2025-05-01)

Inhibitors of Microglial Neurotoxicity: Focus on Natural Products
by: Kyoungho Suk, et al.
Published: (2011-01-01)

The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration
by: Ying Chen, et al.
Published: (2022-02-01)

Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra
by: Chun Huang, et al.
Published: (2017-05-01)

Glial cells in anorexia
by: Daniel Reyes-Haro
Published: (2022-08-01)

Cathelicidin-Related Antimicrobial Peptide Negatively Regulates Bacterial Endotoxin-Induced Glial Activation
by: Anup Bhusal, et al.
Published: (2022-12-01)

Profiling Complement System Components in Primary CNS Vasculitis
by: Milani Deb-Chatterji, et al.
Published: (2021-05-01)

Targeting glial fibrillary acidic protein in glaucoma: a monoclonal antibody approach to modulate glial reactivity and neuroinflammation for neuroprotection
by: Chaoqiang Guan, et al.
Published: (2025-06-01)

Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis
by: Rhian Evans, et al.
Published: (2023-03-01)

Glial PAMPering and DAMPening of Adult Hippocampal Neurogenesis
by: Luke Parkitny, et al.
Published: (2021-09-01)

Neuroprotective and Neurotoxic Effects of Glial-Derived Exosomes
by: Karina Oyarce, et al.
Published: (2022-06-01)

Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease
by: Qinghui Wang, et al.
Published: (2024-11-01)

Glial Contributions to Lafora Disease: A Systematic Review
by: Stefania Della Vecchia, et al.
Published: (2022-12-01)

The alternative complement pathway drives neuroinflammation and neurodegeneration in mouse models of glaucoma and optic nerve injury
by: Cindy Hoppe, et al.
Published: (2025-11-01)

TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
by: Jordi Creus-Muncunill, et al.
Published: (2024-03-01)

Long-Lasting Changes in Glial Cells Isolated From Rats Subjected to the Valproic Acid Model of Autism Spectrum Disorder
by: Marianela Evelyn Traetta, et al.
Published: (2021-08-01)

Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice
by: Jeffrey M. Harder, et al.
Published: (2020-11-01)

Hypoxic Processes Induce Complement Activation via Classical Pathway in Porcine Neuroretinas
by: Ana M. Mueller-Buehl, et al.
Published: (2021-12-01)

Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
by: Mario García-Domínguez
Published: (2025-09-01)

The Role of Oxytocin in Abnormal Brain Development: Effect on Glial Cells and Neuroinflammation
by: Marit Knoop, et al.
Published: (2022-12-01)

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
by: Giulia Magni, et al.
Published: (2024-03-01)

Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders
by: Marta Pérez-González, et al.
Published: (2023-03-01)

Sialylation as a checkpoint for inflammatory and complement-related retinal diseases
by: Yiduo Min, et al.
Published: (2025-06-01)

Pro-neuroinflammatory and neurotoxic potential of extracellular histones H1 and H3
by: Seamus A. McRae, et al.
Published: (2024-07-01)

Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder
by: Albert Frank Magnusen, et al.
Published: (2025-10-01)